Two Sigma Advisers’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Two Sigma Advisers’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,200	Closed	-$23K	–	2770
2021 Q2	$23K	Sell	17,200 -2,800	-14%	-$3.44K	﹤0.01%	2408
2021 Q1	$29K	Sell	20,000 -9,900	-33%	-$15.5K	﹤0.01%	2516
2020 Q4	$40K	Buy	29,900 +1,600	+6%	+$1.89K	﹤0.01%	2334
2020 Q3	$23K	Buy	+28,300	New	+$23.1K	﹤0.01%	2356

Other funds holding BDR

TCM

Tufton Capital Management Hunt Valley, Maryland $596M AUM 37.37% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Advisers's BDR Position: Q3 2021 in Review

Two Sigma Advisers sold out of Blonder Tongue Laboratories Inc (BDR) in Q3 2021, closing a stake of 17,200 shares — an estimated $23K sold.

Two Sigma Advisers first reported a position in BDR in Q3 2020 and held it in 4 quarters. The position peaked at $40K in Q4 2020. 8 funds tracked by Wall St. Rank hold BDR as of Q3 2021.

Two Sigma Advisers reported no remaining Blonder Tongue Laboratories Inc position as of Q3 2021 after selling out during the quarter.
Two Sigma Advisers sold 17,200 Blonder Tongue Laboratories Inc shares in Q3 2021, an estimated $23K.
Two Sigma Advisers first reported a position in Blonder Tongue Laboratories Inc in Q3 2020 and held it in 4 quarters.
Two Sigma Advisers's Blonder Tongue Laboratories Inc position peaked at $40K in Q4 2020.
8 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.